DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail.

[1]  M. Schmitz,et al.  Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways. , 2012, Journal of molecular cell biology.

[2]  R. Gomis,et al.  Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. , 2012, The Journal of clinical investigation.

[3]  Y. Miki,et al.  DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. , 2012, The Journal of clinical investigation.

[4]  M. Nieto,et al.  Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation , 2012, The EMBO journal.

[5]  S. Fox,et al.  The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression , 2011, Breast Cancer Research.

[6]  Y. Tokura,et al.  Expression of SNAI1 and TWIST1 in the eccrine glands of patients with systemic sclerosis: possible involvement of epithelial–mesenchymal transition in the pathogenesis , 2011, The British journal of dermatology.

[7]  C. Perou.  Molecular stratification of triple-negative breast cancers. , 2011, The oncologist.

[8]  Jason I. Herschkowitz,et al.  Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.

[9]  J. Yook,et al.  Role of CK1 in GSK3β-mediated phosphorylation and degradation of Snail , 2010, Oncogene.

[10]  S. Peiró,et al.  Snail Family Regulation and Epithelial Mesenchymal Transitions in Breast Cancer Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[11]  D. Hedley,et al.  SNAI1 expression and the mesenchymal phenotype: an immunohistochemical study performed on 46 cases of oral squamous cell carcinoma , 2010, BMC clinical pathology.

[12]  K. Fukunaga,et al.  Quantitative Measurement of in Vivo Phosphorylation States of Cdk5 Activator p35 by Phos-tag SDS-PAGE* , 2010, Molecular & Cellular Proteomics.

[13]  Nam‐Gyun Kim,et al.  Regulation of protein stability by GSK3 mediated phosphorylation , 2009, Cell cycle.

[14]  Y. Miki,et al.  ATM Augments Nuclear Stabilization of DYRK2 by Inhibiting MDM2 in the Apoptotic Response to DNA Damage* , 2009, The Journal of Biological Chemistry.

[15]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[16]  S. Takeno,et al.  DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer. , 2009, Anticancer research.

[17]  S. Alahari,et al.  Molecular mechanisms controlling E-cadherin expression in breast cancer. , 2009, Biochemical and biophysical research communications.

[18]  E. Kinoshita,et al.  Phos-tag beads as an immunoblotting enhancer for selective detection of phosphoproteins in cell lysates. , 2009, Analytical biochemistry.

[19]  Thomas B Bair,et al.  ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells. , 2009, Molecular biology of the cell.

[20]  Yutaka Kawakami,et al.  Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. , 2009, Cancer cell.

[21]  Simone Brabletz,et al.  E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer , 2009, Cancer and Metastasis Reviews.

[22]  K. Yoshida.  Role for DYRK family kinases on regulation of apoptosis. , 2008, Biochemical pharmacology.

[23]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[24]  H. Höfler,et al.  The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients , 2007, British Journal of Cancer.

[25]  F. Portillo,et al.  SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells. , 2007, Cancer research.

[26]  H. Höfler,et al.  The E-cadherin Repressor Snail Plays a Role in Tumor Progression of Endometrioid Adenocarcinomas , 2007, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[27]  Chun-you Wang,et al.  Expression of snail in pancreatic cancer promotes metastasis and chemoresistance. , 2007, The Journal of surgical research.

[28]  H. Höfler,et al.  Analysis of the E-Cadherin Repressor Snail in Primary Human Cancers , 2007, Cells Tissues Organs.

[29]  A. Cano,et al.  Snail silencing effectively suppresses tumour growth and invasiveness , 2007, Oncogene.

[30]  K. Horwitz,et al.  Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes. , 2006, Cancer research.

[31]  B. Eickholt,et al.  Distinct Priming Kinases Contribute to Differential Regulation of Collapsin Response Mediator Proteins by Glycogen Synthase Kinase-3 in Vivo* , 2006, Journal of Biological Chemistry.

[32]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[33]  R. Lin,et al.  DYRK2 and GSK-3 phosphorylate and promote the timely degradation of OMA-1, a key regulator of the oocyte-to-embryo transition in C. elegans. , 2005, Developmental biology.

[34]  D. Radisky.  Epithelial-mesenchymal transition , 2005, Journal of Cell Science.

[35]  Robert D Cardiff,et al.  The transcriptional repressor Snail promotes mammary tumor recurrence. , 2005, Cancer cell.

[36]  D. Nguyen,et al.  Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions. , 2005, Cancer research.

[37]  M. Hung,et al.  Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition , 2004, Nature Cell Biology.

[38]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[39]  K. Sugimachi,et al.  Transcriptional repressor snail and progression of human hepatocellular carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[41]  G. Moreno-Bueno,et al.  Correlation of Snail expression with histological grade and lymph node status in breast carcinomas , 2002, Oncogene.

[42]  M. Nieto,et al.  The snail superfamily of zinc-finger transcription factors , 2002, Nature Reviews Molecular Cell Biology.

[43]  Philip R. Cohen,et al.  The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. , 2001, The Biochemical journal.

[44]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[45]  A. G. Herreros,et al.  The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.

[46]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .

[47]  M. Takeichi,et al.  Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. , 1993, Cancer research.

[48]  Y. Doki,et al.  Expression of immunoreactive E-cadherin adhesion molecules in human cancers. , 1991, The American journal of pathology.